Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival

Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

(2012) A. Chaidos et al.   BLOOD

Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity

(2012) E. O. Stenger et al.   BLOOD

Human regulatory T cells in allogeneic stem cell transplantation

(2011) S. N. Ukena et al.   BLOOD

Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation

(2011) Y. Kawano et al.   BLOOD

Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism

(2011) D. B. Leveson-Gower et al.   BLOOD

Viral infection prevents diabetes by inducing regulatory T cells through NKT cell–plasmacytoid dendritic cell interplay

(2011) Julien Diana et al.   JOURNAL OF EXPERIMENTAL MEDICINE

NKT Cell Ligand Recognition Logic: Molecular Basis for a Synaptic Duet and Transmission of Inflammatory Effectors

(2011) S. Joyce et al.   JOURNAL OF IMMUNOLOGY

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

(2011) John Koreth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-versus-Host-Disease

(2010) John M. Magenau et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

On the use of donor-derived iNKT cells for adoptive immunotherapy to prevent leukemia recurrence in pediatric recipients of HLA haploidentical HSCT for hematological malignancies

(2010) Paolo Dellabona et al.   CLINICAL IMMUNOLOGY

NKT cells, Treg, and their interactions in bone marrow transplantation

(2010) Holbrook E. Kohrt et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

CD4+CD25+ Regulatory T Cell Depletion Improves the Graft-Versus-Tumor Effect of Donor Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation

(2010) S. Maury et al.   Science Translational Medicine

Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after  -galactosylceramide administration

(2009) R. D. Kuns et al.   BLOOD

Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease

(2009) A. B. Pillai et al.   BLOOD

TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors

(2009) H. E. Kohrt et al.   BLOOD

First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells

(2009) Piotr Trzonkowski et al.   CLINICAL IMMUNOLOGY

Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?

(2009) J. Pidala et al.   HAEMATOLOGICA

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET

Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation

(2009) Jie Yang et al.   TRANSFUSION

A biomarker panel for acute graft-versus-host disease

(2008) S. Paczesny et al.   BLOOD